CVS Health projects at least $405 billion in revenue by 2026 while targeting adjusted earnings per share between $7.30 and $7.50.
CVS Health unveiled its 2026 financial outlook, targeting adjusted earnings per share of $7.30 to $7.50. The company also aims for at least $405 billion in revenue by the end of the period, reflecting long-term growth ambitions.
The guidance follows a year of strategic investments and operational expansions, including acquisitions and healthcare service integrations. Analysts had anticipated a conservative outlook, but the revenue target exceeds prior expectations for the sector.
Markets reacted cautiously, with CVS shares showing modest movement as investors assessed the feasibility of the projections amid industry-wide cost pressures.